$97.10
2.79% yesterday
Nasdaq, Jun 13, 10:00 pm CET
ISIN
US59064R1095
Symbol
MLAB

Mesa Laboratories, Inc. Target price 2025 - Analyst rating & recommendation

Mesa Laboratories, Inc. Classifications & Recommendation:

Buy
33%
Hold
33%
Sell
33%

Mesa Laboratories, Inc. Price Target

Target Price $112.50
Price $97.10
Potential
Number of Estimates 2
2 Analysts have issued a price target Mesa Laboratories, Inc. 2026 . The average Mesa Laboratories, Inc. target price is $112.50. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 3 analysts: 1 Analysts recommend Mesa Laboratories, Inc. to buy, 1 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Mesa Laboratories, Inc. stock has an average upside potential 2026 of .

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Revenue Million $ 240.98 251.00
11.47% 4.16%
EBITDA Margin 13.63% 23.81%
24.05% 74.72%
Net Margin -0.82% 2.91%
99.30% 455.97%

3 Analysts have issued a sales forecast Mesa Laboratories, Inc. 2026 . The average Mesa Laboratories, Inc. sales estimate is

$251m
Unlock
. This is
4.16% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$252m 4.57%
Unlock
, the lowest is
$250m 3.87%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $241m 11.47%
2026
$251m 4.16%
Unlock
2027
$266m 5.98%
Unlock

3 Analysts have issued an Mesa Laboratories, Inc. EBITDA forecast 2026. The average Mesa Laboratories, Inc. EBITDA estimate is

$59.8m
Unlock
. This is
81.99% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$61.1m 86.05%
Unlock
, the lowest is
$58.8m 79.05%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $32.8m 38.27%
2026
$59.8m 81.99%
Unlock
2027
$66.1m 10.65%
Unlock

EBITDA Margin

2025 13.63% 24.05%
2026
23.81% 74.72%
Unlock
2027
24.86% 4.41%
Unlock

2 Mesa Laboratories, Inc. Analysts have issued a net profit forecast 2026. The average Mesa Laboratories, Inc. net profit estimate is

$7.3m
Unlock
. This is
471.57% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$8.9m 551.78%
Unlock
, the lowest is
$5.7m 390.86%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-2.0m 99.23%
2026
$7.3m 471.57%
Unlock
2027
$10.4m 42.08%
Unlock

Net Margin

2025 -0.82% 99.30%
2026
2.91% 455.97%
Unlock
2027
3.91% 34.36%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Mar '25 2026
Estimates
Earnings Per Share $ -0.36 1.34
99.24% 472.22%
P/E 74.54
EV/Sales 2.77

2 Analysts have issued a Mesa Laboratories, Inc. forecast for earnings per share. The average Mesa Laboratories, Inc. EPS is

$1.34
Unlock
. This is
472.22% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$1.63 552.78%
Unlock
, the lowest is
$1.05 391.67%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-0.36 99.24%
2026
$1.34 472.22%
Unlock
2027
$1.91 42.54%
Unlock

P/E ratio

Current -277.47 12,383.57%
2026
74.54 126.86%
Unlock
2027
52.44 29.65%
Unlock

Based on analysts' sales estimates for 2026, the Mesa Laboratories, Inc. stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.89 17.66%
2026
2.77 4.11%
Unlock
2027
2.61 5.64%
Unlock

P/S ratio

Current 2.26 13.51%
2026
2.17 3.99%
Unlock
2027
2.05 5.64%
Unlock

Current Mesa Laboratories, Inc. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked May 30 2025
Evercore ISI Group
Locked
Locked
Locked Oct 01 2024
Wells Fargo
Locked
Locked
Locked Aug 27 2024
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
May 30 2025
Locked
Evercore ISI Group:
Locked
Locked
Oct 01 2024
Locked
Wells Fargo:
Locked
Locked
Aug 27 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today